Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study

Few studies have reported on the clinical utility of targeted next-generation sequencing (NGS) for breast cancer in Korea. We retrospectively reviewed the targeted NGS data of 219 patients with breast cancer who underwent surgical resection between August 2018 and April 2021. Here, we described the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung Ho, Kwon, Mi Jung, Seo, Jinwon, Kim, Ho Young, Min, Soo Kee, Kim, Lee Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629967/
https://www.ncbi.nlm.nih.gov/pubmed/36265889
http://dx.doi.org/10.4048/jbc.2022.25.e41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629967/
https://www.ncbi.nlm.nih.gov/pubmed/36265889
http://dx.doi.org/10.4048/jbc.2022.25.e41

Ejemplares similares